Aspirin prevention of cancer metastasis (WP5518)

Homo sapiens

Platelets generate TXA2, which binds to its receptor (TP) on T cells, initiating the activation of ARHGEF1, a guanine exchange factor that promotes the conversion of RhoA from its inactive GDP-bound state to its active GTP-bound form. This RhoA activation inhibits TCR-induced kinase pathways, T cell proliferation, and effector functions, ultimately suppressing anti-metastatic immunity. TXA2 production by platelets is COX1-dependent and can be blocked by aspirin or COX-1 selective inhibitors, which relieve T cells from TXA2-mediated suppression. Inspired by figure 14 in in Yang et al. (2025)..

Authors

Eric Weitz

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Annotations

Pathway Ontology

cancer pathway acetylsalicylic acid drug pathway

Cell Type Ontology

T cell neoplastic cell platelet

Disease Ontology

cancer

Participants

Label Type Compact URI Comment
Aspirin Metabolite chebi:15365
PGH2 Metabolite chebi:15554
TXA2 Metabolite chebi:15627
GDP Metabolite chebi:17552
GTP Metabolite chebi:15996
PTGS1 GeneProduct ensembl:ENSG00000095303
TBXAS1 GeneProduct ensembl:ENSG00000059377
TBXA2R GeneProduct ensembl:ENSG00000006638
GNA12 GeneProduct ensembl:ENSG00000146535
TRG GeneProduct ensembl:6965
GNA13 GeneProduct ensembl:ENSG00000120063
ARHGEF1 GeneProduct ensembl:ENSG00000076928
RHOA GeneProduct ensembl:ENSG00000067560
TRA GeneProduct ncbigene:6955
TRB GeneProduct ncbigene:6957
TRD GeneProduct ncbigene:6964

References

  1. Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity. Yang J, Yamashita-Kanemaru Y, Morris BI, Contursi A, Trajkovski D, Xu J, et al. Nature. 2025 Mar 5;10.1038/s41586-025-08626–7. PubMed Europe PMC Scholia